Why Is Bristol Myers Squibb Stock Trading Lower On Thursday?

Discover Bristol Myers Squibb's impressive first-quarter performance, with revenues exceeding expectations driven by key products like Eliquis and Reblozyl. Despite challenges, the company aims for significant cost savings and future growth.

Related Keywords

William Blair , Bristol Myers Squibb Co , Bristol Myers Squibb , Legacy Portfolio , Myers Squibb ,